Bethesda III and IV Thyroid Nodules Managed Nonoperatively after Molecular Testing with Afirma GSC or Thyroseq v3.
Na Eun KimRajam S RaghunathanElena G HughesXochitl R LongstaffChi-Hong TsengShanpeng LiDianne S CheungYaroslav A GofnungPouyan FaminiJames X WuMichael W YehMasha J LivhitsPublished in: The Journal of clinical endocrinology and metabolism (2023)
The majority of Bethesda III/IV thyroid nodules with negative or benign molecular test results are stable over 3 years of follow-up. These findings support the high sensitivity of current molecular tests and their role in ruling out malignancy in indeterminate thyroid nodules.
Keyphrases